[Renal involvement in antineutrophil cytoplasmic antibodies (ANCA) associated vasculitides. Recommendations of the Chilean Societies of Nephrology and Rheumatology]

Rev Med Chil. 2018 Feb;146(2):241-248. doi: 10.4067/s0034-98872018000200241.
[Article in Spanish]

Abstract

Renal involvement is a frequent complication in antineutrophil cytoplasmic antibodies (ANCA)associated vasculitides, adding morbidity and mortality, such as chronic kidney disease and the need for renal replacement therapy. With the aim of reaching a consensus on relevant issues regarding the diagnosis, treatment and follow-up of patients with these diseases, the Chilean Societies of Nephrology and Rheumatology formed a working group that, based on a critical review of the available literature and their experience, raised and answered consensually a set of questions relevant to the subject. This document includes aspects related to the clinical diagnosis, the histological characteristics, the therapeutic alternatives to induce and maintain the remission of the disease, relapse surveillance strategies and complementary therapies.

Publication types

  • Practice Guideline

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / blood
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / complications*
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / diagnosis
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / therapy
  • Antibodies, Antineutrophil Cytoplasmic / blood*
  • Chile
  • Humans
  • Kidney Diseases / etiology*
  • Kidney Diseases / therapy*
  • Maintenance Chemotherapy
  • Remission Induction
  • Societies, Medical

Substances

  • Antibodies, Antineutrophil Cytoplasmic